PETMED EXPRESS INC (PETS)
US7163821066 - Common Stock
Taking everything into account, PETS scores 3 out of 10 in our fundamental rating. PETS was compared to 123 industry peers in the Specialty Retail industry. PETS scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. PETS is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
PETS had negative earnings in the past year.
PETS had a negative operating cash flow in the past year.
Of the past 5 years PETS 4 years were profitable.
Each year in the past 5 years PETS had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of -2.20%, PETS is in line with its industry, outperforming 43.80% of the companies in the same industry.
Looking at the Return On Equity, with a value of -3.59%, PETS is in line with its industry, outperforming 51.24% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.2% | ||
| ROE | -3.59% | ||
| ROIC | N/A |
ROA(3y)2.57%
ROA(5y)8.14%
ROE(3y)2.43%
ROE(5y)9.77%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a Gross Margin value of 27.36%, PETS is not doing good in the industry: 72.73% of the companies in the same industry are doing better.
PETS's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for PETS so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 27.36% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.27%
GM growth 5Y-3.61%
2. Health
2.1 Basic Checks
PETS does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for PETS has been increased compared to 1 year ago.
Compared to 5 years ago, PETS has more shares outstanding
PETS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
An Altman-Z score of 3.45 indicates that PETS is not in any danger for bankruptcy at the moment.
With a decent Altman-Z score value of 3.45, PETS is doing good in the industry, outperforming 75.21% of the companies in the same industry.
There is no outstanding debt for PETS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 3.45 |
ROIC/WACCN/A
WACC9.3%
2.3 Liquidity
PETS has a Current Ratio of 1.33. This is a normal value and indicates that PETS is financially healthy and should not expect problems in meeting its short term obligations.
PETS has a Current ratio (1.33) which is in line with its industry peers.
A Quick Ratio of 0.89 indicates that PETS may have some problems paying its short term obligations.
PETS has a Quick ratio of 0.89. This is in the better half of the industry: PETS outperforms 73.55% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.33 | ||
| Quick Ratio | 0.89 |
3. Growth
3.1 Past
PETS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 79.31%, which is quite impressive.
Looking at the last year, PETS shows a quite strong growth in Revenue. The Revenue has grown by 9.41% in the last year.
PETS shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.17% yearly.
EPS 1Y (TTM)79.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)9.41%
Revenue growth 3Y-3.13%
Revenue growth 5Y-0.17%
Sales Q2Q%-16.1%
3.2 Future
PETS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 31.76% yearly.
The Revenue is expected to grow by 1.08% on average over the next years.
EPS Next Y122.23%
EPS Next 2Y37.2%
EPS Next 3Y31.76%
EPS Next 5YN/A
Revenue Next Year-4.84%
Revenue Next 2Y-0.87%
Revenue Next 3Y1.08%
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for PETS. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for PETS. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, PETS is valued a bit cheaper than 62.81% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 9.17 |
4.3 Compensation for Growth
PETS's earnings are expected to grow with 31.76% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.2%
EPS Next 3Y31.76%
5. Dividend
5.1 Amount
PETS does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
PETMED EXPRESS INC
NASDAQ:PETS (11/7/2024, 8:00:00 PM)
After market: 5.74 +0.01 (+0.17%)5.73
+1.51 (+35.78%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap118.04M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.2% | ||
| ROE | -3.59% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 27.36% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.77
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.33 | ||
| Quick Ratio | 0.89 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)79.31%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y122.23%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)9.41%
Revenue growth 3Y-3.13%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y